Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.
Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.
Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on a patented formulation providing controlled and prolonged exposure of antigens and adjuvant to the immune system : DepoVax.